YOUR SEARCH FOR Text 257 RESULTS
231 of Total
Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
232 of Total
Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
233 of Total
Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance
234 of Total
Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs
235 of Total
Incyte Reports 2024 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
236 of Total
Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
237 of Total
Incyte Reports 2024 Fourth Quarter and Year-End Financial Results, Provides 2025 Financial Guidance
238 of Total
Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs
239 of Total
Incyte Reports 2025 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
240 of Total
Incyte Announces New 24-Week Phase 3 Data from the STOP-HS Clinical Trial Program of Povorcitinib in